ImmunoPrecise Begins Path to NASDAQ

This morning ImmunoPrecise Antibodies Ltd (TSXV: IPA) announced they have commenced the application process to dual list their stock on the NASDAQ. In the news release, the company states they believe the move will gain greater exposure for the company to access a larger base of retail and institutional investors in the United States and internationally.

ImmunoPrecise Antibodies Ltd. Logo (CNW Group/ImmunoPrecise Antibodies Ltd.)

ImmunoPrecise is a full-service, therapeutic antibody discovery company utilizing species agnostic, multi-format, characterized and engineered, human monoclonal antibodies, on an abbreviated timeframe. IPA has developed a technology platform with end-to-end solutions empowering companies to discover and develop therapies against any disease. Their full-service capabilities reduce the time and risk associated with conventional multi-vendor product development.

The company has been working on COVID by identifying antibodies derived from multiple species (human, llama, Ligand’s humanized OmniRat, and wild-type rabbits) which demonstrate potent, in vitro neutralizing activity. They have discovered their functional antibodies using the Company’s DeepDisplay phage technology, B Cell Select and Single Step Hybridoma platforms.

At the time of publishing IPA stock is trading at $1.85 an increase of 3.9%.


Information for this analysis was found via Sedar and ImmunoPrecise Antibodies Ltd. The author is long common shares of ImmunoPrecise Antibodies (IPA.v). Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

200 Grams of Gold And 21% Copper — That’s Not Normal | Matt Wilson – Sterling Metals

Silver at $100? This Time It Might Stay There. | David Morgan

Critical Minerals Are Rerating! | John Passalacqua – First Phosphate

Recommended

Steadright Enters MOU To Acquire Historic Goundafa Polymetallic Mine In Morocco

Military Seizes Power in Madagascar After President Flees

Related News

Sona Nanotech Withdraws Health Canada Application For COVID-19 Test Due To Feedback From Regulator

In what is a major blow to shareholders of Sona Nanotech (CSE: SONA), the company...

Wednesday, November 25, 2020, 02:31:06 PM

Amazon Preparing To Lay Off Another 9,000 Workers

Amazon is preparing to let go another 9,000 workers over the next several weeks, in...

Monday, March 20, 2023, 01:14:38 PM

Auditor General Cites $27.4 Billion COVID Benefit Payments Still Unverified, $4.6 Billion Overpayments To Ineligible Recipients

The report also noted the successful speed in obtaining and distributing COVID-19 vaccines but millions...

Wednesday, December 7, 2022, 07:56:44 AM

Tesla Stops Nearly All Production at Shanghai Factory Amid Parts Shortages

Tesla (NASDAQ: TSLA) has reportedly suspended nearly all production at its Shanghai factory, after running...

Tuesday, May 10, 2022, 05:04:00 PM

US Thanksgiving Air Travel Rebounds to Highest Level Since Beginning of Pandemic– But Still Nearly 50% Below 2019 Traffic

Despite the CDC warning Americans against travelling for the Thanksgiving holiday amid soaring Covid-19 infection...

Monday, November 30, 2020, 03:33:00 PM